Robin Swartz

This profile gathers the share dealings of Robin Swartz in Voyager Therapeutics, Inc. We count 22 filings; the first trade dates from 21 March 2022 and the latest from 24 February 2026.

On the market, this insider has only sold: 18 sales, €417k in total. The rest of the record consists of 4 share grants. In 2026 alone, the filings show no purchases and 3 sales.

The latest filing, published on 26 February 2026, reports an open-market sale of €21k in Voyager Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.